Woodcock Said To Have Guided Hydroxychloroquine EUA In ‘Brokered Compromise’ To Limit Use

 
• By Derrick Gingery
Coronavirus stocks
Former BARDA Director Rick Bright said in a whistleblower complaint that he worried about widespread use of chloroquine as a coronavirus treatment, given its limited efficacy data and adverse event profile. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet